Correlation of growth fraction by Ki-67 and proliferating cell nuclear antigen (PCNA) immunohistochemistry with histopathological parameters and prognosis in primary breast carcinomas

Breast Cancer Research and Treatment

Volumn 37, Issue 2, 1996, Pages 101-113

  Haerslev, Torben ^a   Jacobsen, Grete Krag ^a   Zedeler, Karin ^a  

^a UNIVERSITY OF COPENHAGEN   (Denmark)

Author keywords

Breast carcinomas; Immunohistochemistry; Ki 67; Multivariate analysis; Prognosis; Proliferating cell nuclear antigen PCNA

Indexed keywords

ANTIBODY; BUFFER; CITRIC ACID; CYCLINE; FORMALDEHYDE; MONOCLONAL ANTIBODY KI 67; PARAFFIN; STEROID RECEPTOR;

ADULT; AGED; ARTICLE; BREAST CARCINOMA; CANCER GRADING; CANCER SURVIVAL; CONTROLLED STUDY; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MICROWAVE OVEN; MULTIVARIATE ANALYSIS; PHENOTYPE; PRIORITY JOURNAL; PROGNOSIS; STORAGE; TISSUE SECTION; TUMOR DIFFERENTIATION; TUMOR VOLUME;

ADULT; AGED; AGED, 80 AND OVER; BREAST NEOPLASMS; CARCINOMA; CELL DIVISION; COHORT STUDIES; FEMALE; FOLLOW-UP STUDIES; HUMANS; IMMUNOHISTOCHEMISTRY; KI-67 ANTIGEN; MIDDLE AGED; NEOPLASM PROTEINS; NUCLEAR PROTEINS; PROGNOSIS; PROLIFERATING CELL NUCLEAR ANTIGEN; STATISTICS;

EID: 0030061315     PISSN: 01676806     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF01806492     Document Type: Article

References (44)

1. Ewertz M, Carstensen B: Trends in breast cancer incidence and mortality in Denmark. 1943-1982. Int J Cancer 41:46-51, 1988
2. Rosai J: Ackerman's surgical pathology. The C.V. Mosby Company, St. Louis, 1989
3. Meyer J, McDivitt R, Stone K, Prey M, Bauer W: Practical breast carcinoma cell kinetics: a review and update. Breast Cancer Res Treat 4: 79-88, 1984
4. Meyer J, Province M: Proliferation index of breast carcinoma by thymidine labelling: prognostic power independent of stage, estrogen and progesterone receptor. Breast Cancer Res Treat 12: 191-204, 1988
5. Tubiana M, Koscielny S: Cell kinetics, growth rate and the natural history of breast cancer. The Heuson memorial lecture. Eur J Cancer Clin Oncol 24: 9-14, 1988
6. Tubiana M, Pejovic M, Koscielny S, Chvaudra N, Malaise E: Growth rate, kinetics of tumour cell proliferation and long-term outcome in human breast cancer. Int J Cancer 44: 17-22, 1989
7. Tubiana M, Courdi A: Cell proliferation kinetics in human solid tumours: relation to probability of metastasis, dissemination, and long-term survival. Radiother Oncol 15: 1-18, 1989
8. McGuire W, Tandon A, Allred DC, Chamness G, Clark G: How to use prognostic factors in axillary node-negative breast cancer patients. J Natl Cancer Inst 82:1006-1015, 1990
9. Graem N, Helweg-Larsen K: Mitotic activity and delay in fixation of tissues. Acta Pathol Microbiol Scand (A) 87:375-379, 1979
10. Donhuijsen K, Schmidt U, Horche H, van Beuningen D, Budach V: Changes in mitotic rate and cell cycle fractions caused by delayed fixation. Hum Pathol 21: 709-714, 1990
11. Clayton F: Pathologic correlates of survival in 378 lymph node-negative infiltrating ductal carcinomas: mitotic count is the best single predictor. Cancer 68: 1309-1317, 1991
12. Gerdes J, Lemke H, Baisch H, Wacker H-H, Schwab U, Stein H: Cell cycle analysis of a cell proliferation-associated human nuclear antigen defined by the monoclonal antibody Ki-67. J Immunol 133: 1710-1715, 1984
13. Gerdes J, Lelle R, Pickartz H, Heidenreich W, Schwarting R, Kurtsiefer L, Stauch G, Stein H: Growth fractions in breast cancers determined in situ with monoclonal antibody Ki-67. J Clin Pathol 39: 977-980, 1986
14. Mathews M, Bernstein R, Franza B, Garrels J: Identity of the proliferating cell nuclear antigen and cyclin. Nature 303: 374-376, 1984
15. Celis J, Bravo R, Larsen P, Fey SJ: Cyclin: a nuclear protein whose level correlates with the proliferative state of normal as well as transformed cells. Leuk Res 8: 143-147, 1984
16. Garcia R, Coltera M, Gown A: Analysis of proliferative grade using anti-PCNA/cyclin monoclonal antibodies in fixed, embedded tissues. Am J Pathol 134: 733-739, 1989
17. Siitonen S, Kallioniemi O-P, Isola J: Proliferating cell nuclear antigen immunohistochemistry using monoclonal antibody 19A2 and a new antigen retrieval technique has prognostic impact in archival paraffin-embedded node-negative breast cancer. Am J Pathol 142: 1081-1089, 1993
18. Battersby S, Andersson T: Correlation of proliferative activity in breast tissue using PCNA/cyclin. Hum Pathol 21: 781, 1990
19. Haerslev T, Jacobsen GK: Proliferating cell nuclear antigen (PCNA) in breast carcinomas. An immunohistochemical study with correlation to histopathological features and prognostic factors. Virchow Archiv A 424: 39-46, 1994
20. Dervan P, Magee H, Buckley C, Carney D: Proliferating cell nuclear antigen counts in formalin-fixed paraffin-embedded tissue correlate with Ki-67 in fresh tissue. Am J Clin Pathol 97: S21-S28, 1992
21. Andersen K., Mouridsen H, Castberg T, Fischerman K, Andersen J, Hou-Jensen K, Brincker H, Johansen H, Henriksen E, Rorth M, Rossing N: Organization of the Danish adjuvant trials in breast cancer. Danish Med Bull 28: 102-106, 1981
22. World Health Organization: Histological typing of breast tumours. WHO, Geneva, 1968
23. Bloom HJG, Richardson WW: Histological grading and prognosis in breast cancer. Br J Cancer 11: 359-377, 1957
24. Kaplan E, Meier P: Nonparametric estimation from incomplete observations. J Am Stat Assoc 53: 457-481, 1958
25. Cox D, Oakes D: Analysis of survival data. London, 1984
26. Haerslev T, Jacobsen GK: Microwave processing for immunohistochemical demonstration of proliferating cell nuclear antigen (PCNA) in formalin-fixed and paraffin-embedded tissue. APMIS 102: 395-400, 1994
27. Sabatti E, Gerdes J, Ghelinzoni F, Poggi S, Zucchini L, Melili G, Grigioni F, Del Vecchio M, Leoncini L, Falini B, Pileri S: Comparison between the monoclonal antibodies Ki-67 and PC-10 in 125 malignant lymphomas. J Pathol 169: 397-403, 1993
28. Yu CC-W, Wilkinson N, Brito MJ, Buckley C, Fox H, Levison D: Patterns of immunohistochemical staining for proliferating nuclear antigen and p53 in benign and neoplastic human endometrium. Histopathology 23: 367-371, 1993
29. Cattoretti G, Becker M. Key G, Duchrow M, Schlüter C, Galle J, Gerdes J; Monoclonal antibodies against recombinant parts of the Ki-67 antigen (MIB 1 and MIB 3) detect proliferating cells in microwave-processed formalin-fixed paraffin sections. J Pathol 168: 357-363, 1992
30. Kurki P, Vanderlaan M, Dolbeare F, Gray J, Tan E: Expression of proliferating cell nuclear antigen (PCNA)/cyclin during the cell cycle. Exp Cell Res 166: 209-219, 1986
31. Siitonen S, Isola J, Rantala I, Helin H: Intratumor variation in cell proliferation in breast carcinoma as determined by anti-PCNA monoclonal antibody and automated image analysis. Am J Clin Pathol 99: 226-231, 1993
32. Suzuki K, Katoh R, Kawaoki A: Immunohistochemical demonstration of proliferating cell nuclear antigen (PCNA) in formalin-fixed, paraffin-embedded sections from rat and human tissues. Acta Histochem Cytochem 25: 13-21, 1992
33. Leong A-Y, Milios J, Tang S: Is immunolocalisation of proliferating cell nuclear antigen (PCNA) in paraffin sections a valid index of cell proliferation? Appl Immunohistochem 12: 127-135, 1993
34. He W, Meyer JS, Scrivner DL, Koehm S, Hughes J: Assessment of proliferating cell nuclear antigen (PCNA) in breast cancer using anti-PCNA PC10 and 19A2: correlation with 5-bromo-2'-deoxyuridine or tritiatcd thymidine labeling and flow cytometric analysis. Biotech & Histochem 69: 203-212, 1994
35. BarnardN, Hall P, Lemoine N, Kadar N: Proliferative index in breast carcinoma determined in situ by Ki-67 immunostaining and its relationship to clinical and pathological variables. J Pathol 152: 287-295, 1987
36. Locker A, Birrell K, Bell J. Nicholson R, Elston C, Blarney R, Ellis I: Ki67 immunoreactivity in breast carcinoma: relationship to prognostic variables and short term survival. Eur J Surg Oncol 18: 224-229, 1992
37. Vielh P, Chevillard S, Mosseri V, Donatini B, Magdelenat H: Ki67 index and S-phase fraction in human breast carcinomas. Comparison and correlations with prognostic factors. Am J Clin Pathol 94: 681-686, 1990
38. Tahan S, Neuberg D, Dieffenbach A, Yacoub L: Prediction of early relapse and shortened survival in patients with breast cancer by proliferating cell nuclear antigen score. Cancer 71: 3552-3559, 1993
39. Mango W, Hirchfield L, Bhuiya T, Harrison G, Mir R: Correlation of proliferating cell nuclear antigen (PCNA) and Ki-67 reactivity in primary breast carcinoma with hormone and disease-free survival. Conn Med 56: 667-669, 1992
40. Linden MD, Ma CK, Kubus J, Brown RD, Zarbo RJ: Ki-67 and proliferating cell nuclear antigen, tumour proliferative indices in DNA diploid colorectal adcnocarcinomas. Correlation with histopathologic characteristics and cell cycle analysis with two-color DNA flow cytometry. Am J Clin Pathol 100: 206-212, 1993
41. Bravo R, MacDonald H: Existence of two populations of cyclins/proliferating cell nuclear antigen during the cell cycle: association with DNA replication sites. J Cell Biol 105: 1549-1554, 1987
42. Aaltomaa S, Lipponen P, Eskelinen M, Kosma V-M, Marin S, Alhava E, Syrjänen K: Prognostic factors after 5 years follow-up in female breast cancer. Oncology 49: 49, 1993
43. Weikel W, Beck T, Mitze M, Knapstein P: Immunohistochemical evaluation of growth fractions in human breast cancers using monoclonal antibody Ki-67. Breast Cancer Res Treat 18: 149-154, 1991
44. Gasparini S, Meli S, Pozza S, Cazzavilillan S, Beliacqua P: PC-10 antibody to proliferating cell nuclear antigen (PCNA) is not related to prognosis in human breast carcinomas. Growth Res 2: 145-150, 1992